Literature DB >> 6319583

Class-specific antibody responses to early and late antigens of varicella and herpes simplex viruses.

N J Schmidt, D Gallo.   

Abstract

Antibody responses to early antigens of varicella-zoster virus (VZV), simian varicella virus, and herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) were studied in primary, secondary, and latent infections. IgG antibody responses to the early antigens occurred in primary and secondary VZV and HSV infections, and antibodies to early antigens were also demonstrable in healthy individuals with latent VZV and HSV infections, indicating that the presence of antibodies to early antigens cannot be taken as evidence of active infection with the viruses. Patients with current VZV or HSV infections showed heterotypic IgG antibody responses to early antigens of VZV and HSV to the same extent as to late antigens. In all groups of patients, IgG antibody titers to early antigens were similar to those against the corresponding late antigens, and no difference was seen in the reactivity of early antigens produced with four different blocking agents (cytosine arabinoside, bromodeoxyuridine, trisodium phosphonoformate, and cycloheximide). Antibodies of the IgM and IgA classes reacted with both early and late antigens of HSV, but only with late antigens of VZV and simian varicella virus, suggesting that these antibodies may be directed against late proteins that are expressed to a greater extent in HSV-infected cells treated with blocking agents than they are expressed in treated VZV-infected cells. Homologous IgM antibody responses occurred in both primary and secondary VZV infections, but only in primary HSV infections. Heterotypic IgM responses to HSV-2 antigen were noted in a few VZV patients who did not have demonstrable IgG antibody to HSV, suggesting that even in patients without prior experience with HSV, a VZV infection may stimulate the production of IgM antibodies that react with antigens that are shared by VZV and HSV-2. IgA antibodies to late antigens of VZV and HSV were demonstrable in latent, as well as active, infections with these viruses.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6319583     DOI: 10.1002/jmv.1890130102

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  7 in total

1.  Sensitivity of different assay systems for immunoglobulin M responses to varicella-zoster virus in reactivated infections (zoster).

Authors:  N J Schmidt; A M Arvin
Journal:  J Clin Microbiol       Date:  1986-05       Impact factor: 5.948

2.  Detection of antibodies against initial polypeptides in patients infected with an enterovirus (EV-33).

Authors:  M Aouni; O Gaudin; B Pozzetto; J C le Bihan
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

3.  Anomalous antibody responses in viral infection: specific stimulation or polyclonal activation?

Authors:  N E Cremer; V L Devlin; J L Riggs; S J Hagens
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

4.  Serologic detection of active infections with human herpes viruses (CMV, EBV, HSV, VZV): diagnostic potential of IgA class and IgG subclass-specific antibodies.

Authors:  H W Doerr; M Rentschler; G Scheifler
Journal:  Infection       Date:  1987 Mar-Apr       Impact factor: 3.553

5.  Virus-specific polymeric immunoglobulin A antibodies in serum from patients with rubella, measles, varicella, and herpes zoster virus infections.

Authors:  A Negro Ponzi; C Merlino; A Angeretti; R Penna
Journal:  J Clin Microbiol       Date:  1985-10       Impact factor: 5.948

Review 6.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

Review 7.  Recognition and treatment of shingles.

Authors:  A F Nikkels; G E Piérard
Journal:  Drugs       Date:  1994-10       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.